Online Programme - EUNF

EUNF 2026 Programme Overview

Thursday, November 12, 2026

	Lecture Hall 1	Lecture Hall 2
12:00 - 12:10	Welcome
12:10 - 12:40	Keynote 1: From Neural Crest to Schwann Cell Lineage
12:40 - 14:30	Plenary 1: Genetic Aspects of Neurofibromatosis Type 1, Schwannomatosis and Related Disorders
14:30 - 15:00	Coffee Break / Posters / Exhibition
15:00 - 16:30	Clinical Session 1: Neuropsychosocial Implications	Basic Session 1: Preclinical Models for Neurofibromatosis Type 1 and Schwannomatosis Pathogenesis
16:30 - 16:45	Coffee Break / Posters / Exhibition
16:45 - 18:15	Clinical Session 2 (Joint with Basic Science) - Bone and Orthopaedic Aspects of NF1	Basic Session 2: Basic Biology underlying Neurofibromatosis Type 1 and Schwannomatosis
18:30 - 21:00	Welcome Reception and Poster Area

	Lecture Hall 1	Lecture Hall 2
12:00 - 12:10	Welcome
12:10 - 12:40	Keynote 1: From Neural Crest to Schwann Cell Lineage
12:40 - 14:30	Plenary 1: Genetic Aspects of Neurofibromatosis Type 1, Schwannomatosis and Related Disorders
14:30 - 15:00	Coffee Break / Posters / Exhibition
15:00 - 16:30	Clinical Session 1: Neuropsychosocial Implications	Basic Session 1: Preclinical Models for Neurofibromatosis Type 1 and Schwannomatosis Pathogenesis
16:30 - 16:45	Coffee Break / Posters / Exhibition
16:45 - 18:15	Clinical Session 2 (Joint with Basic Science) - Bone and Orthopaedic Aspects of NF1	Basic Session 2: Basic Biology underlying Neurofibromatosis Type 1 and Schwannomatosis
18:30 - 21:00	Welcome Reception and Poster Area

	Lecture Hall 1
12:00 - 12:10	Welcome
12:10 - 12:40	Keynote 1: From Neural Crest to Schwann Cell Lineage
12:40 - 14:30	Plenary 1: Genetic Aspects of Neurofibromatosis Type 1, Schwannomatosis and Related Disorders
14:30 - 15:00	Coffee Break / Posters / Exhibition
15:00 - 16:30	Clinical Session 1: Neuropsychosocial Implications
16:30 - 16:45	Coffee Break / Posters / Exhibition
16:45 - 18:15	Clinical Session 2 (Joint with Basic Science) - Bone and Orthopaedic Aspects of NF1
18:30 - 21:00	Welcome Reception and Poster Area

	Lecture Hall 2
12:00 - 12:10	Welcome
12:10 - 12:40	Keynote 1: From Neural Crest to Schwann Cell Lineage
12:40 - 14:30	Plenary 1: Genetic Aspects of Neurofibromatosis Type 1, Schwannomatosis and Related Disorders
14:30 - 15:00	Coffee Break / Posters / Exhibition
15:00 - 16:30	Basic Session 1: Preclinical Models for Neurofibromatosis Type 1 and Schwannomatosis Pathogenesis
16:30 - 16:45	Coffee Break / Posters / Exhibition
16:45 - 18:15	Basic Session 2: Basic Biology underlying Neurofibromatosis Type 1 and Schwannomatosis
18:30 - 21:00	Welcome Reception and Poster Area

Friday, November 13, 2026

	Lecture Hall 1	Lecture Hall 2
7:00 - 8:00		The Great NF / SWN Challenge: Pearls, Pitfalls and Prizes! - For Early Birds and Wise Owls!
8:00 - 9:30	Clinical Session 3: Visible Manifestations in Neurofibromatosis	Basic Session 3: Basic and Translational Research in Schwannomatosis: Selected from Abstracts
9:30 - 9:50	Coffee Break / Posters / Exhibition
9:50 - 10:20	Keynote 2: Evidence to Action: How Advocacy Works Best
10:20 - 12:00	Plenary 2: Together - Patient Involvement in Research and Clinic
12:05 - 13:05	Industry Symposium (Alexion, AstraZeneca Rare Disease): Clinical Evidence and Expert Insights on the Management of NF1-PN
13:10 - 14:25	Plenary 3 - Part 1: Pexiform Neurofibroma
14:25 - 14:50	Coffee Break / Posters / Exhibition
14:50 - 16:10	Plenary 3 - Part 2: Malignant Progression from Neurofibroma to MPNST
16:10 - 16:30	Coffee Break / Posters / Exhibition
16:30 - 18:00	Clinical Session 4: SWN Basket Session (Pain, Hybrid Tumours, etc.)	Basic Session 4: Basic and Translational Research in Neurofibromatosis Type 1: Selected from Abstracts
19:30 - 23:00	Conference Dinner

	Lecture Hall 1	Lecture Hall 2
7:00 - 8:00		The Great NF / SWN Challenge: Pearls, Pitfalls and Prizes! - For Early Birds and Wise Owls!
8:00 - 9:30	Clinical Session 3: Visible Manifestations in Neurofibromatosis	Basic Session 3: Basic and Translational Research in Schwannomatosis: Selected from Abstracts
9:30 - 9:50	Coffee Break / Posters / Exhibition
9:50 - 10:20	Keynote 2: Evidence to Action: How Advocacy Works Best
10:20 - 12:00	Plenary 2: Together - Patient Involvement in Research and Clinic
12:05 - 13:05	Industry Symposium (Alexion, AstraZeneca Rare Disease): Clinical Evidence and Expert Insights on the Management of NF1-PN
13:10 - 14:25	Plenary 3 - Part 1: Pexiform Neurofibroma
14:25 - 14:50	Coffee Break / Posters / Exhibition
14:50 - 16:10	Plenary 3 - Part 2: Malignant Progression from Neurofibroma to MPNST
16:10 - 16:30	Coffee Break / Posters / Exhibition
16:30 - 18:00	Clinical Session 4: SWN Basket Session (Pain, Hybrid Tumours, etc.)	Basic Session 4: Basic and Translational Research in Neurofibromatosis Type 1: Selected from Abstracts
19:30 - 23:00	Conference Dinner

	Lecture Hall 1
7:00 - 8:00
8:00 - 9:30	Clinical Session 3: Visible Manifestations in Neurofibromatosis
9:30 - 9:50	Coffee Break / Posters / Exhibition
9:50 - 10:20	Keynote 2: Evidence to Action: How Advocacy Works Best
10:20 - 12:00	Plenary 2: Together - Patient Involvement in Research and Clinic
12:05 - 13:05	Industry Symposium (Alexion, AstraZeneca Rare Disease): Clinical Evidence and Expert Insights on the Management of NF1-PN
13:10 - 14:25	Plenary 3 - Part 1: Pexiform Neurofibroma
14:25 - 14:50	Coffee Break / Posters / Exhibition
14:50 - 16:10	Plenary 3 - Part 2: Malignant Progression from Neurofibroma to MPNST
16:10 - 16:30	Coffee Break / Posters / Exhibition
16:30 - 18:00	Clinical Session 4: SWN Basket Session (Pain, Hybrid Tumours, etc.)
19:30 - 23:00	Conference Dinner

	Lecture Hall 2
7:00 - 8:00	The Great NF / SWN Challenge: Pearls, Pitfalls and Prizes! - For Early Birds and Wise Owls!
8:00 - 9:30	Basic Session 3: Basic and Translational Research in Schwannomatosis: Selected from Abstracts
9:30 - 9:50	Coffee Break / Posters / Exhibition
9:50 - 10:20	Keynote 2: Evidence to Action: How Advocacy Works Best
10:20 - 12:00	Plenary 2: Together - Patient Involvement in Research and Clinic
12:05 - 13:05	Industry Symposium (Alexion, AstraZeneca Rare Disease): Clinical Evidence and Expert Insights on the Management of NF1-PN
13:10 - 14:25	Plenary 3 - Part 1: Pexiform Neurofibroma
14:25 - 14:50	Coffee Break / Posters / Exhibition
14:50 - 16:10	Plenary 3 - Part 2: Malignant Progression from Neurofibroma to MPNST
16:10 - 16:30	Coffee Break / Posters / Exhibition
16:30 - 18:00	Basic Session 4: Basic and Translational Research in Neurofibromatosis Type 1: Selected from Abstracts
19:30 - 23:00	Conference Dinner

Saturday, November 14, 2026

	Lecture Hall 1	Lecture Hall 2
8:00 - 8:45	Keynote 3: Organoids
8:45 - 10:10	Plenary 4: CNS Tumours in Neurofibromatosis Type 1 and Schwannomatosis
10:10 - 10:30	Coffee Break / Posters / Exhibition
10:30 - 11:50	Clinical Session 5: Imaging in Neurofibromatosis / SWN	Basic Session 5: Genomics and Bioinformatics for Neurofibromatosis Type 1 and Schwannomatosis
11:55 - 12:55	Industry Symposium (MERCK): CARE FOR RARE: NF1-PN Management in Practice: A Focus on Pain, Evidence, and Clinical Cases	Industry Symposium (MERCK): CARE FOR RARE: NF1-PN Management in Practice: A Focus on Pain, Evidence, and Clinical Cases (Transmission from Lecture Hall 1)
13:00 - 14:00	Clinical Session 6: Rare / Miscellaneous Manifestations	Basic Session 6: AI and Big Data in Neurofibromatosis Type 1 and Schwannomatosis Research
14:00 - 14:20	Coffee Break / Posters / Exhibition
14:20 - 14:50	Best Poster Awards & Lifetime Achievement Award
14:40 - 15:30	Theodor Schwann Awards and Talks by Awardees
15:30 - 16:30	Plenary 5: New Therapeutic Developments - Future Clinical Trials and Clinical Trial Design - Preclinical Drug Development – Part 1
16:30 - 16:45	Coffee Break / Posters / Exhibition
16:45 - 18:00	Plenary 5: New Therapeutic Developments - Future Clinical Trials and Clinical Trial Design - Preclinical Drug Development – Part 2
18:00 - 18:15	Meeting Closure / Farewell

	Lecture Hall 1	Lecture Hall 2
8:00 - 8:45	Keynote 3: Organoids
8:45 - 10:10	Plenary 4: CNS Tumours in Neurofibromatosis Type 1 and Schwannomatosis
10:10 - 10:30	Coffee Break / Posters / Exhibition
10:30 - 11:50	Clinical Session 5: Imaging in Neurofibromatosis / SWN	Basic Session 5: Genomics and Bioinformatics for Neurofibromatosis Type 1 and Schwannomatosis
11:55 - 12:55	Industry Symposium (MERCK): CARE FOR RARE: NF1-PN Management in Practice: A Focus on Pain, Evidence, and Clinical Cases	Industry Symposium (MERCK): CARE FOR RARE: NF1-PN Management in Practice: A Focus on Pain, Evidence, and Clinical Cases (Transmission from Lecture Hall 1)
13:00 - 14:00	Clinical Session 6: Rare / Miscellaneous Manifestations	Basic Session 6: AI and Big Data in Neurofibromatosis Type 1 and Schwannomatosis Research
14:00 - 14:20	Coffee Break / Posters / Exhibition
14:20 - 14:50	Best Poster Awards & Lifetime Achievement Award
14:40 - 15:30	Theodor Schwann Awards and Talks by Awardees
15:30 - 16:30	Plenary 5: New Therapeutic Developments - Future Clinical Trials and Clinical Trial Design - Preclinical Drug Development – Part 1
16:30 - 16:45	Coffee Break / Posters / Exhibition
16:45 - 18:00	Plenary 5: New Therapeutic Developments - Future Clinical Trials and Clinical Trial Design - Preclinical Drug Development – Part 2
18:00 - 18:15	Meeting Closure / Farewell

	Lecture Hall 1
8:00 - 8:45	Keynote 3: Organoids
8:45 - 10:10	Plenary 4: CNS Tumours in Neurofibromatosis Type 1 and Schwannomatosis
10:10 - 10:30	Coffee Break / Posters / Exhibition
10:30 - 11:50	Clinical Session 5: Imaging in Neurofibromatosis / SWN
11:55 - 12:55	Industry Symposium (MERCK): CARE FOR RARE: NF1-PN Management in Practice: A Focus on Pain, Evidence, and Clinical Cases
13:00 - 14:00	Clinical Session 6: Rare / Miscellaneous Manifestations
14:00 - 14:20	Coffee Break / Posters / Exhibition
14:20 - 14:50	Best Poster Awards & Lifetime Achievement Award
14:40 - 15:30	Theodor Schwann Awards and Talks by Awardees
15:30 - 16:30	Plenary 5: New Therapeutic Developments - Future Clinical Trials and Clinical Trial Design - Preclinical Drug Development – Part 1
16:30 - 16:45	Coffee Break / Posters / Exhibition
16:45 - 18:00	Plenary 5: New Therapeutic Developments - Future Clinical Trials and Clinical Trial Design - Preclinical Drug Development – Part 2
18:00 - 18:15	Meeting Closure / Farewell

	Lecture Hall 2
8:00 - 8:45	Keynote 3: Organoids
8:45 - 10:10	Plenary 4: CNS Tumours in Neurofibromatosis Type 1 and Schwannomatosis
10:10 - 10:30	Coffee Break / Posters / Exhibition
10:30 - 11:50	Basic Session 5: Genomics and Bioinformatics for Neurofibromatosis Type 1 and Schwannomatosis
11:55 - 12:55	Industry Symposium (MERCK): CARE FOR RARE: NF1-PN Management in Practice: A Focus on Pain, Evidence, and Clinical Cases (Transmission from Lecture Hall 1)
13:00 - 14:00	Basic Session 6: AI and Big Data in Neurofibromatosis Type 1 and Schwannomatosis Research
14:00 - 14:20	Coffee Break / Posters / Exhibition
14:20 - 14:50	Best Poster Awards & Lifetime Achievement Award
14:40 - 15:30	Theodor Schwann Awards and Talks by Awardees
15:30 - 16:30	Plenary 5: New Therapeutic Developments - Future Clinical Trials and Clinical Trial Design - Preclinical Drug Development – Part 1
16:30 - 16:45	Coffee Break / Posters / Exhibition
16:45 - 18:00	Plenary 5: New Therapeutic Developments - Future Clinical Trials and Clinical Trial Design - Preclinical Drug Development – Part 2
18:00 - 18:15	Meeting Closure / Farewell

You need to enable JavaScript to access this site.

Follow these instructions on how to enable JavaScript.

Internet Explorer

Select Tools from the top menu
Choose Internet Options
Click on the Security tab
Click on Custom Level
Scroll down until you see the section labelled Scripting
Under Active Scripting, select Enable and click OK

Google Chrome

Select the menu icon on the browser toolbar
Select Settings
Click the Show advanced settings... link then Content Settings in the Privacy section
Select Allow all sites to run JavaScript (recommended) and click Done

Safari (Mac)

Select Safari from the top menu
Choose Preferences
Choose Security
Select the checkbox next to Enable JavaScript